13148_2019_775_MOESM2_ESM.pptx (663.26 kB)
MOESM2 of Phase I/II intra-patient dose escalation study of vorinostat in children with relapsed solid tumor, lymphoma, or leukemia
presentation
posted on 2019-12-11, 10:43 authored by Cornelis van Tilburg, Till Milde, Ruth Witt, Jonas Ecker, Thomas Hielscher, Angelika Seitz, Jens-Peter Schenk, Juliane Buhl, Dennis Riehl, Michael Frühwald, Arnulf Pekrun, Claudia Rossig, Regina Wieland, Christian Flotho, Uwe Kordes, Bernd Gruhn, Thorsten Simon, Christin Linderkamp, Felix Sahm, Lenka Taylor, Angelika Freitag, Jürgen Burhenne, Kathrin Foerster, Andreas Meid, Stefan Pfister, Irini Karapanagiotou-Schenkel, Olaf WittAdditional file 2: Figure S2. a Plot of pairwise correlations (Spearman) of baseline concentrations of individual cytokines. b Heatmap of baseline concentrations (Gehan u-score) of a selection of 9 cytokines. c Longitudinal analysis of mean values of cytokines, separated by MTD groups. d Longitudinal analysis of mean values of cytokines, separated by best response groups.
